RESUMEN
Virginia cedarwood oil is widely used as a fragrance material in household and personal products and as a naturally derived pesticide alternative. Due to conflicting literature on dermal exposures in animals and humans, concern for safe levels of human exposure remains. The present study evaluated the toxicity of cedarwood oil applied dermally to F344/N rats and B6C3F1/N mice for 13 weeks. Groups of 10 male and female rats and mice received no treatment (untreated control) or were administered cedarwood oil in 95% aqueous ethanol dermally at concentrations ranging from 0% (vehicle control), 6.25%, 12.5%, 25%, 50%, and 100% (undiluted). Rats and mice developed extensive skin lesions at the site of application. Benchmark dose modeling (BMD) was performed for the significantly increased skin lesions observed in the rat, to provide perspective for risk assessment applications. Benchmark dose modeling levels (BMDL) of 0.65 to 2.1% and 1.2 to 4.4% (equivalent to 13 to 42 mg/kg and 24 to 48 mg/kg, respectively) cedarwood oil were calculated for the most sensitive endpoint of epidermal hyperplasia in female rats and chronic active inflammation in male rats, respectively. These BMDL levels coincide with reported use levels in cosmetics and pesticides, raising the concern for human exposure.
Asunto(s)
Aceites Volátiles/toxicidad , Aceites de Plantas/toxicidad , Enfermedades de la Piel/inducido químicamente , Pruebas de Toxicidad/métodos , Administración Cutánea , Animales , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Aceites Volátiles/administración & dosificación , Aceites de Plantas/administración & dosificación , Ratas , Ratas Endogámicas F344 , Enfermedades de la Piel/patologíaRESUMEN
Cumene hydroperoxide (CHP) is a high production volume chemical that is used to generate phenol and acetone. Dermal exposure to CHP was hypothesized to result in systemic tissue toxicity, production of free radicals, and consequent decrease in plasma antioxidant levels. To evaluate the hypothesis and characterize the toxicity of CHP, male and female B6C3F1/N mice and F344/N rats were exposed to varying doses of CHP applied topically for 14 or 90 days. No significant changes in survival or body weight of mice and rats were observed following 14 days of exposure. However, 90 days of CHP exposure at the high dose (12 mg/kg) triggered a significant decrease (-15%) in the body weight of the male rat group only. Irritation of the skin was observed at the site of application and was characterized by inflammation and epidermal hyperplasia. In treated animals, histology of liver tissue, free radical generation, and antioxidant levels in blood plasma were not significantly changed as compared to the corresponding controls. Consistent with the lack of systemic damage, no increase in micronucleated erythrocytes was seen in peripheral blood. In conclusion, topical CHP application caused skin damage only at the application site and did not cause systemic tissue impairment.
Asunto(s)
Derivados del Benceno/toxicidad , Oxidantes/toxicidad , Piel/efectos de los fármacos , Administración Cutánea , Animales , Derivados del Benceno/administración & dosificación , Femenino , Masculino , Ratones , Oxidantes/administración & dosificación , Ratas , Ratas Endogámicas F344RESUMEN
Ginkgo biloba extract (GBE) is a popular herbal supplement that is used to improve circulation and brain function. In spite of widespread human exposure to relatively high doses over potentially long periods of time, there is a paucity of data from animal studies regarding the toxicity and carcinogenicity associated with GBE. In order to fill this knowledge gap, 3-month and 2-year toxicity and carcinogenicity studies with GBE administered by oral gavage to B6C3F1/N mice and F344/N rats were performed as part of the National Toxicology Program's Dietary Supplements and Herbal Medicines Initiative. The targets of GBE treatment were the liver, thyroid, and nose. These targets were consistent across exposure period, sex, and species, albeit with varying degrees of effect observed among studies. Key findings included a notably high incidence of hepatoblastomas in male and female mice and evidence of carcinogenic potential in the thyroid gland of both mice and rats. Various nonneoplastic lesions were observed beyond control levels in the liver, thyroid gland, and nose of rats and mice administered GBE. Although these results cannot be directly extrapolated to humans, the findings fill an important data gap in assessing risk associated with GBE use.
Asunto(s)
Ginkgo biloba/toxicidad , Hígado/efectos de los fármacos , Nariz/efectos de los fármacos , Extractos Vegetales/toxicidad , Glándula Tiroides/efectos de los fármacos , Animales , Pruebas de Carcinogenicidad , Carcinógenos/toxicidad , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Femenino , Ginkgo biloba/química , Hígado/patología , Masculino , Ratones , Ratones Endogámicos , Nariz/patología , Tamaño de los Órganos/efectos de los fármacos , Extractos Vegetales/química , Ratas , Ratas Endogámicas F344 , Glándula Tiroides/patologíaRESUMEN
In this study we assessed the relative toxicity and potency of the chlorinated naphthalenes 1,2,3,4,6,7-hexachloronaphthalene (PCN 66) and 1,2,3,5,6,7-hexachloronaphthalene (PCN 67) relative to that of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Chemicals were administered in corn oil:acetone (99:1) by gavage to female Harlan Sprague-Dawley rats at dosages of 0 (vehicle), 500, 1500, 5000, 50,000 and 500,000 ng/kg (PCN 66 and PCN 67) and 1, 3, 10, 100, and 300 ng/kg (TCDD) for 2 weeks. Histopathologic changes were observed in the thymus, liver and lung of TCDD treated animals and in the liver and thymus of PCN treated animals. Significant increases in CYP1A1 and CYP1A2 associated enzyme activity were observed in all animals exposed to TCDD, PCN 66 and PCN 67. Dose response modeling of CYP1A1, CYP1A2 and thymic atrophy gave ranges of estimated relative potencies, as compared to TCDD, of 0.0015-0.0072, for PCN 66 and 0.00029-0.00067 for PCN 67. Given that PCN 66 and PCN 67 exposure resulted in biochemical and histopathologic changes similar to that seen with TCDD, this suggests that they should be included in the WHO toxic equivalency factor (TEF) scheme, although the estimated relative potencies indicate that these hexachlorinated naphthalenes should not contribute greatly to the overall human body burden of dioxin-like activity.
Asunto(s)
Citocromo P-450 CYP1A1/biosíntesis , Citocromo P-450 CYP1A2/biosíntesis , Hidrocarburos Clorados/toxicidad , Naftalenos/toxicidad , Dibenzodioxinas Policloradas/toxicidad , Animales , Atrofia , Relación Dosis-Respuesta a Droga , Inducción Enzimática/efectos de los fármacos , Femenino , Hidrocarburos Clorados/administración & dosificación , Naftalenos/administración & dosificación , Dibenzodioxinas Policloradas/administración & dosificación , Ratas , Ratas Sprague-Dawley , Timo/efectos de los fármacos , Timo/patologíaRESUMEN
Kava Kava is an herbal supplement used as an alternative to antianxiety drugs. Although some reports suggest an association of Kava Kava with hepatotoxicity , it continues to be used in the United States due to lack of toxicity characterization. In these studies F344/N rats and B6C3F1 mice were administered Kava Kava extract orally by gavage in corn oil for two weeks, thirteen weeks or two years. Results from prechronic studies administered Kava Kava at 0.125 to 2g/kg body weight revealed dose-related increases in liver weights and incidences of hepatocellular hypertrophy. In the chronic studies, there were dose-related increases in the incidences of hepatocellular hypertrophy in rats and mice administered Kava Kava for up to 1g/kg body weight. This was accompanied by significant increases in incidences of centrilobular fatty change. There was no treatment- related increase in carcinogenic activity in the livers of male or female rats in the chronic studies. Male mice showed a significant dose-related increase in the incidence of hepatoblastomas. In female mice, there was a significant increase in the combined incidence of hepatocellular adenoma and carcinoma in the low and mid dose groups but not in the high dose group. These findings were accompanied by several nonneoplastic hepatic lesions.
Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas , Kava/toxicidad , Animales , Pruebas de Carcinogenicidad , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Femenino , Hígado/patología , Masculino , Ratones , Ratones Endogámicos , Ratas , Ratas Endogámicas F344 , Caracteres SexualesRESUMEN
Serum corticosterone is used as a biomarker of stress in laboratory rats for the evaluation of the response to experimental stressors. Environmental (animal handling) influences can confound the experiment by introducing extraneous stressors. The purpose of this study was to evaluate the use of carbon dioxide-oxygen anesthesia, with two different animal handling techniques, as an appropriate procedure for the collection of serum samples for corticosterone determinations in male and female Fischer 344 rats. The design of the study mimicked the initiation of a toxicity study, but only sham dosing occurred prior to blood collection. Animals were divided into two groups, acclimated and nonacclimated. Acclimated animals were anesthetized in their home cage, whereas nonacclimated animals were anesthetized in a separate anesthesia chamber. Blood was obtained from the retro-orbital plexus under carbon dioxide-oxygen anesthesia after the fourth day of sham administration of 0.5% aqueous methylcellulose. Serum corticosterone was measured by radioimmunoassay. Mean serum corticosterone concentrations in acclimated male and female rats were approximately 25% and 50% those of nonacclimated animals, respectively. Serum corticosterone concentrations in the acclimated groups were similar to those published for Fischer 344 rats after blood collection by decapitation and were lower than concentrations in studies using other collection methods. A minor change in the handling technique by anesthetizing animals in their home cage can result in reliable baseline corticosterone concentrations in male and female Fischer 344 rats. This refinement in technique will allow for decreased animal stress and decreased animal numbers (reuse of animal for future bleeds). These improvements in animal use can lead to better corticosterone data and lower variability on a given toxicology study.